To identify the molecular mechanisms underlying the oncogenic role of LINC01468 in HCC, an RNA pull-down assay and western blot analysis were used to determine whether SHIP2 is associated with LINC01468. The gene discussed is LNCAROD; the disease is hepatocellular carcinoma.